115 related articles for article (PubMed ID: 159863)
1. Restoration of impaired immune functions of aged animals by chronic bestatin treatment.
Bruley-Rosset M; Florentin I; Kiger N; Schulz J; Mathé G
Immunology; 1979 Sep; 38(1):75-83. PubMed ID: 159863
[TBL] [Abstract][Full Text] [Related]
2. Acceleration of age-associated immune decline and mortality by early repeated administration of bestatin to C57BL/6 mice.
Bruley-Rosset M; Payelle B; Rappaport H
J Biol Response Mod; 1986 Apr; 5(2):176-90. PubMed ID: 3488372
[TBL] [Abstract][Full Text] [Related]
3. Correction of immunodeficiency in aged mice by levamisole and bestatin administration.
Bruley-Rosset M; Florentin I; Kiger N; Schulz JI; Mathé G
Recent Results Cancer Res; 1980; 75():139-46. PubMed ID: 7232825
[TBL] [Abstract][Full Text] [Related]
4. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
[TBL] [Abstract][Full Text] [Related]
5. Effects of Bacillus Calmette-Guérin and levamisole on immune responses in young adult and age-immunodepressed mice.
Bruley-Rosset M; Florentin I; Kiger N; Davigny M; Mathé G
Cancer Treat Rep; 1978 Nov; 62(11):1641-50. PubMed ID: 728893
[TBL] [Abstract][Full Text] [Related]
6. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.
Schorlemmer HU; Bosslet K; Sedlacek HH
Cancer Res; 1983 Sep; 43(9):4148-53. PubMed ID: 6871856
[TBL] [Abstract][Full Text] [Related]
7. Immunopotentiation in infectious disease, I. Effect of bestatin on the immune response.
Ormrod DJ; Cawley S; Miller TE
Chemioterapia; 1985 Aug; 4(4):313-23. PubMed ID: 3876888
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory and therapeutic properties of bestatin in mice.
Talmadge JE; Lenz BF; Pennington R; Long C; Phillips H; Schneider M; Tribble H
Cancer Res; 1986 Sep; 46(9):4505-10. PubMed ID: 2942238
[TBL] [Abstract][Full Text] [Related]
9. Do tuftsin and bestatin constitute a biopharmacological immunoregulatory system?
Mathé G
Cancer Detect Prev Suppl; 1987; 1():445-55. PubMed ID: 3319151
[TBL] [Abstract][Full Text] [Related]
10. The effects of bestatin on humoral response to sheep erythrocytes in non-treated and cyclophosphamide-immunocompromised mice.
Lis M; Szczypka M; Suszko A; Obmińska-Mrukowicz B
Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):133-8. PubMed ID: 22957713
[TBL] [Abstract][Full Text] [Related]
11. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
[TBL] [Abstract][Full Text] [Related]
12. Mitogenic effect of bestatin on lymphocytes.
Ishizuka M; Sato J; Sugiyama Y; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1980 Jun; 33(6):653-62. PubMed ID: 7419476
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
14. Study of the effect of single or multiple doses of BCG on antibody-dependent cellular cytotoxicity.
Kiger N; Bruley-Rosset M; Huchet R; Mathe G
Immunology; 1980 Nov; 41(3):687-94. PubMed ID: 6970164
[TBL] [Abstract][Full Text] [Related]
15. Recovery of age-dependent immunological deterioration in old mice by thyroxine treatment.
El-Shaikh KA; Gabry MS; Othman GA
J Anim Physiol Anim Nutr (Berl); 2006 Jun; 90(5-6):244-54. PubMed ID: 16684146
[TBL] [Abstract][Full Text] [Related]
16. Effects of recombinant murine tumor necrosis factor-alpha on immune function.
Gordon C; Wofsy D
J Immunol; 1990 Mar; 144(5):1753-8. PubMed ID: 2307839
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of delayed-type hypersensitivity to high dose sheep erythrocytes by cyclosporin A in the mouse: influence of drug dosage and route of administration and analysis of spleen cell populations.
Webster LM; Thomson AW
Clin Exp Immunol; 1988 Jan; 71(1):149-54. PubMed ID: 3349644
[TBL] [Abstract][Full Text] [Related]
18. [A new antitumor drug with immunomodulating activity, ubenimex (bestatin)].
Tsukagoshi S
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2385-91. PubMed ID: 3496857
[TBL] [Abstract][Full Text] [Related]
19. Matching of chemotherapy to mouse strain and lymphoid tumor type to prevent tumor-induced suppression of specific T- and B-cell functions.
Faanes RB; Merluzzi VJ; Williams N; Tarnowski GS; Ralph P
Cancer Res; 1979 Nov; 39(11):4564-74. PubMed ID: 315269
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
